标题
Our 2015 approach to invasive pulmonary aspergillosis
作者
关键词
-
出版物
MYCOSES
Volume 58, Issue 6, Pages 375-382
出版商
Wiley
发表日期
2015-03-25
DOI
10.1111/myc.12319
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Fungus-Specific CD4+T Cells for Rapid Identification of Invasive Pulmonary Mold Infection
- (2015) Petra Bacher et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Combination Antifungal Therapy for Invasive Aspergillosis
- (2015) Kieren A. Marr et al. ANNALS OF INTERNAL MEDICINE
- Safety and Pharmacokinetics of Isavuconazole as Antifungal Prophylaxis in Acute Myeloid Leukemia Patients with Neutropenia: Results of a Phase 2, Dose Escalation Study
- (2015) Oliver A. Cornely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- How to interpret serum levels of beta-glucan for the diagnosis of invasive fungal infections in adult high-risk hematology patients: optimal cut-off levels and confounding factors
- (2015) H. Hammarström et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany
- (2015) J. Steinmann et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Diagnostic value of bronchoscopy in patients with hematologic malignancy and pulmonary infiltrates
- (2014) Sei Won Kim et al. ANNALS OF HEMATOLOGY
- Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology
- (2014) Daniela Tacke et al. ANNALS OF HEMATOLOGY
- Phase 1b Study of New Posaconazole Tablet for Prevention of Invasive Fungal Infections in High-Risk Patients with Neutropenia
- (2014) Rafael F. Duarte et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Serum Galactomannan-Based Early Detection of Invasive Aspergillosis in Hematology Patients Receiving Effective Antimold Prophylaxis
- (2014) R. F. Duarte et al. CLINICAL INFECTIOUS DISEASES
- Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study
- (2014) N. Lerolle et al. CLINICAL MICROBIOLOGY AND INFECTION
- European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) and European Confederation of Medical Mycology (ECMM) 2013 joint guidelines on diagnosis and management of rare and emerging fungal diseases
- (2014) O.A. Cornely et al. CLINICAL MICROBIOLOGY AND INFECTION
- ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013
- (2014) O.A. Cornely et al. CLINICAL MICROBIOLOGY AND INFECTION
- Performance of Galactomannan, Beta-D-Glucan, Aspergillus Lateral-Flow Device, Conventional Culture, and PCR Tests with Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis
- (2014) M. Hoenigl et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation
- (2014) Andreas H Groll et al. LANCET ONCOLOGY
- Automation of serum (1->3)-beta-D-glucan testing allows reliable and rapid discrimination of patients with and without candidemia
- (2014) F. Pruller et al. MEDICAL MYCOLOGY
- Randomised, multicentre trial of micafungin vs. an institutional standard regimen for salvage treatment of invasive aspergillosis
- (2014) Oliver A. Cornely et al. MYCOSES
- Our 2014 approach to candidaemia
- (2014) Philipp Koehler et al. MYCOSES
- Our 2014 approach to mucormycosis
- (2014) Daniela Tacke et al. MYCOSES
- Genetic PTX3 Deficiency and Aspergillosis in Stem-Cell Transplantation
- (2014) Cristina Cunha et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence of Cyp51 A Key Mutations in Aspergillus fumigatus—A Study on Primary Clinical Samples of Immunocompromised Patients in the Period of 1995–2013
- (2014) Birgit Spiess et al. PLoS One
- Bronchoalveolar Lavage Lateral-Flow Device Test for Invasive Pulmonary Aspergillosis in Solid Organ Transplant Patients
- (2014) Birgit Willinger et al. TRANSPLANTATION
- Fungal Infections After Liver Transplantation: Incidence and Outcome
- (2014) G. Sganga et al. TRANSPLANTATION PROCEEDINGS
- Treatment of invasive fungal infections in cancer patients—updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
- (2013) Sabine Mousset et al. ANNALS OF HEMATOLOGY
- Diagnosis and management of gastrointestinal complications in adult cancer patients: evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
- (2013) M. J. G. T. Vehreschild et al. ANNALS OF ONCOLOGY
- Treatment cost development of patients undergoing remission induction chemotherapy: a pharmacoeconomic analysis before and after introduction of posaconazole prophylaxis
- (2013) Sebastian M. Heimann et al. MYCOSES
- Human Genetic Susceptibility to Invasive Aspergillosis
- (2013) Cristina Cunha et al. PLoS Pathogens
- Pharmacokinetics of Different Dosing Strategies of Oral Posaconazole in Patients with Compromised Gastrointestinal Function and Who Are at High Risk for Invasive Fungal Infection
- (2012) Oliver A. Cornely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Posaconazole Therapeutic Drug Monitoring: Exposure-Response Relationship and Factors Affecting Concentration
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Development of Novel PCR Assays To Detect Azole Resistance-Mediating Mutations of theAspergillus fumigatus cyp51AGene in Primary Clinical Samples from Neutropenic Patients
- (2012) Birgit Spiess et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Analysis of initial and follow-up CT findings in patients with invasive pulmonary aspergillosis after solid organ transplantation
- (2012) C. Lim et al. CLINICAL RADIOLOGY
- Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome
- (2012) J. J. Vehreschild et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Christopher J L Murray et al. LANCET
- Impact of the revised (2008) EORTC/MSG definitions for invasive fungal disease on the rates of diagnosis of invasive aspergillosis
- (2012) Dimitris A. Tsitsikas et al. MEDICAL MYCOLOGY
- Risk Factors, Clinical Characteristics, and Outcomes of Invasive Fungal Infections in Solid Organ Transplant Recipients
- (2012) M. Bodro et al. TRANSPLANTATION PROCEEDINGS
- Diagnosis of invasive fungal infections in hematology and oncology--guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO)
- (2011) M. Ruhnke et al. ANNALS OF ONCOLOGY
- Phase II Dose Escalation Study of Caspofungin for Invasive Aspergillosis
- (2011) O. A. Cornely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patients
- (2011) L. Potenza et al. BLOOD
- ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients
- (2011) O Marchetti et al. BONE MARROW TRANSPLANTATION
- Lack of Evidence for Exposure–Response Relationship in the Use of Posaconazole as Prophylaxis Against Invasive Fungal Infections
- (2011) O A Cornely et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period
- (2011) M. R. Ananda-Rajah et al. HAEMATOLOGICA
- Clinically defined chemotherapy-associated bowel syndrome predicts severe complications and death in cancer patients
- (2011) M. J. G. T. Vehreschild et al. HAEMATOLOGICA
- Current issues in the clinical management of invasive aspergillosis - the AGIHO, DMykG, ÖGMM and PEG web-based survey and expert consensus conference 2009
- (2011) M. J. G. T. Rüping et al. MYCOSES
- The economic costs to United States hospitals of invasive fungal infections in transplant patients
- (2010) Joseph Menzin et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Efficacy, Safety, and Breakthrough Infections Associated with Standard Long-Term Posaconazole Antifungal Prophylaxis in Allogeneic Stem Cell Transplantation Recipients
- (2010) Drew J. Winston et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Exposure–Response of Posaconazole Used for Prophylaxis Against Invasive Fungal Infections: Evaluating the Need to Adjust Doses Based on Drug Concentrations in Plasma
- (2010) S H Jang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort
- (2010) J. J. Vehreschild et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC/MSG 2008 definitions of invasive mould disease
- (2010) Oliver A. Cornely et al. MYCOSES
- Factors Influencing Pharmacokinetics of Prophylactic Posaconazole in Patients Undergoing Allogeneic Stem Cell Transplantation
- (2009) V. Kohl et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome
- (2009) J. Guinea et al. CLINICAL MICROBIOLOGY AND INFECTION
- Treatment outcome of invasive mould disease after sequential exposure to azoles and liposomal amphotericin B
- (2009) O. A. Cornely et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Voriconazole serum concentrations in prophylactically treated acute myelogenous leukaemia patients
- (2009) Maria J. G. T. Rüping et al. MYCOSES
- Treatment of invasive fungal infections in cancer patients—Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
- (2008) Angelika Böhme et al. ANNALS OF HEMATOLOGY
- Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
- (2008) Thomas J. Walsh et al. CLINICAL INFECTIOUS DISEASES
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
- (2008) Ben De Pauw et al. CLINICAL INFECTIOUS DISEASES
- Galactomannan in Bronchoalveolar Lavage Fluid
- (2007) Wouter Meersseman et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now